Date Title
November 30, 2018
Realm Therapeutics - Holding(s) in Company
RNS Number : 1171J Realm Therapeutics PLC 30 November 2018   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of
November 30, 2018
Realm Therapeutics - Form 8.3 - Realm Therapeutics plc
RNS Number : 0950J Realm Therapeutics PLC 30 November 2018   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of
November 29, 2018
Realm Therapeutics - Holding(s) in Company
RNS Number : 9309I Realm Therapeutics PLC 29 November 2018   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of
November 29, 2018
Realm Therapeutics - Form 8.3 - Realm Therapeutics plc
RNS Number : 9227I Realm Therapeutics PLC 29 November 2018   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of
November 29, 2018
Realm Therapeutics - Update on Strategic Review
RNS Number : 7939I Realm Therapeutics PLC 29 November 2018     THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY
November 28, 2018
Realm Therapeutics - Form 8.3 - Realm Therapeutics plc
RNS Number : 7636I Realm Therapeutics PLC 28 November 2018   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of
November 27, 2018
Realm Therapeutics - Form 8.3 - Realm Therapeutics plc
RNS Number : 6877I Realm Therapeutics PLC 27 November 2018   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of
November 26, 2018
Realm Therapeutics - Form 8.3 - Realm Therapeutics plc
RNS Number : 4553I Realm Therapeutics PLC 26 November 2018   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of
November 7, 2018
Realm Therapeutics - Form 8.3 - Realm Therapeutics plc
RNS Number : 6162G Realm Therapeutics PLC 07 November 2018   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of
November 2, 2018
Realm Therapeutics - Form 8.3 - Realm Therapeutics plc
RNS Number : 1979G Realm Therapeutics PLC 02 November 2018   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of
Displaying 21 - 30 of 165

Search Investor Relations